PGE2 signal through EP2 promotes the growth of articular chondrocytes

Journal of Bone and Mineral Research

Volumn 20, Issue 3, 2005, Pages 377-389

  Aoyama, Tomoki ^a   Liang, Bojian ^b   Okamoto, Takeshi ^a,b   Matsusaki, Takashi ^b   Nishijo, Koichi ^a,b   Ishibe, Tatsuya ^a,b   Yasura, Ko ^a   Nagayama, Satoshi ^c   Nakayama, Tomitaka ^b   Nakamura, Takashi ^b   Toguchida, Junya ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Articular cartilage; Chondrocyte; EP2; Microarray; Prostaglandin E2

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA5 INTEGRIN; BROXURIDINE; CYCLIC AMP; CYCLIN D1; CYCLINE; FIBRONECTIN; INDOMETACIN; MESSENGER RNA; PROSTAGLANDIN E; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E1 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN E3 RECEPTOR; PROSTAGLANDIN E4; PROSTAGLANDIN E4 RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROTEIN P53; PROTEOGLYCAN; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL ASSAY; CELL GROWTH; CELL LEVEL; CELL PROLIFERATION; CELL STRAIN; CHILD; CONTROLLED STUDY; CULTURE TECHNIQUE; DNA DETERMINATION; DNA MICROARRAY; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMUR; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN CULTURE; PLEIOTROPY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE GENETICS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; ANIMALS; CARTILAGE, ARTICULAR; CELL LINE; CELL PROLIFERATION; CHILD; CHONDROCYTES; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; OXYTOCICS; RATS; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION;

EID: 20044370085     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.041122     Document Type: Article

References (50)

1. Lippiello L, Yamamoto K, Robinson D, Mankin HJ 1978 Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism. Arthritis Rheum 21:909-917.
2. Fulkerson JP, Damiano P 1983 Effect of prostaglandin E2 on adult pig articular cartilage slices in culture. Clin Orthop 179:266-269.
3. Kosher RA, Walker KH 1983 The effect of prostaglandins on in vitro limb cartilage differentiation. Exp Cell Res 145:145-153.
4. Biddulph DM, Sawyer LM, Dozier MM 1988 Chondrogenesis in chick limb mesenchyme in vitro derived from distal limb bud tips: Changes in cyclic AMP and in prostaglandin responsiveness. J Cell Physiol 136:81-87.
5. Del Toro F Jr, Sylvia VL, Schubkegel SR, Campos R, Dean DD, Boyan BD, Schwartz Z 2000 Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes. J Cell Physiol 182:196-208.
6. Negishi M, Sugimoto Y, Ichikawa A 1995 Prostaglandin E receptors. J Lipid Mediat Cell Signal 12:379-391.
7. Negishi M, Hasegawa H, Ichikawa A 1996 Prostaglandin E receptor EP3gamma isoform, with mostly full constitutive Gi activity and agonist-dependent Gs activity. FEBS Lett 386:165-168.
8. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S 1993 Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365:166-170.
9. Sylvia VL, Del Toro F, Dean DD, Hardin RR, Schwartz Z, Boyan BD 2001 Effects of 1alpha,25-(OH)(2)D(3) on rat growth zone chondrocytes are mediated via cyclooxygenase-1 and phospholipase A(2). J Cell Biochem 81:32-45.
10. Sylvia VL, Del Toro F Jr, Hardin RR, Dean DD, Boyan BD, Schwartz Z 2001 Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes. J Steroid Biochem Mol Biol 78:261-274.
11. Miyamoto M, Ito H, Mukai S, Kobayashi T, Yamamoto H, Kobayashi M, Maruyama T, Akiyama H, Nakamura T 2003 Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage 11:644-652.
12. Iwamoto M, Higuchi Y, Koyama E, Enomoto-Iwamoto M, Kurisu K, Yeh H, Abrams WR, Rosenbloom J, Pacifici M 2000 Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. J Cell Biol 150:27-40.
13. Iwamoto M, Higuchi Y, Enomoto-Iwamoto M, Kurisu K, Koyama E, Yeh H, Rosenbloom J, Pacifici M 2001 The role of ERG (ets related gene) in cartilage development. Osteoarthritis Cartilage 9(Suppl A):S41-S47.
14. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC 1994 Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22:3551-3555.
15. Levine AJ 1997 p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
16. Shimoji M, Hattori K, Itoh S, Nakayama K, Katsuki M, Aizawa S, Yokoi T, Kamataki T 1995 Establishment of immortal hepatocytes from a CYP3A7-transgenic/p53-knockout mouse. Biochem Biophys Res Commun 217:1001-1005.
17. Yahanda AM, Bruner JM, Donehower LA, Morrison RS 1995 Astocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol 15:4249-4259.
18. Ghosh-Choudhury N, Harris MA, Wozney J, Mundy GR, Harris SE 1997 Clonal osteoblastic cell lines from p53 null mouse calvariae are immortalized and dependent on bone morphogenetic protein 2 for mature osteoblastic phenotype. Biochem Biophys Res Commun 231:196-202.
19. -/- mice: New insights into osteoblast and adipocyte differentiation. J Bone Miner Res 13:195-204.
20. Nakayama T, Kanoe H, Sasaki MS, Aizawa S, Nakamura T, Toguchida J 1997 Establishment of an osteoblast-like cell line, MMC2, from p53-deficient mouse. Bone 21:313-319.
21. -/- mice. J Bone Miner Res 18:97-107.
22. Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shukunami C, Iijima S, Suzuki F, Kondo J 1997 Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 272:32419-32426.
23. Breyer RM 2001 Prostaglandin EP(1) receptor subtype selectivity takes shape. Mol Pharmacol 59:1357-1359.
24. Gomi K, Zhu FG, Marshall JS 2000 Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism. J Immunol 165:6545-6552.
25. Kurihara Y, Endo H, Akahoshi T, Kondo H 2001 Up-regulation of prostaglandin E receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis. Clin Exp Immunol 123:323-330.
26. Paralkar VM, Borovecki F, Ke HZ, Cameron KO, Lefker B, Grasser WA, Owen TA, Li M, DaSilva-Jardine P, Zhou M, Dunn RL, Dumont F, Korsmeyer R, Krasney P, Brown TA, Plowchalk D, Vukicevic S, Thompson DD 2003 An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci USA 100:6736-6740.
27. Li M, Ke HZ, Qi H, Healy DR, Li Y, Crawford DT, Paralkar VM, Owen TA, Cameron KO, Lefker BA, Brown TA, Thompson DD 2003 A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 18:2033-2042.
28. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, Yamaguchi K, Segi E, Tsuboyama T, Matsushita M, Ito K, Ito Y, Sugimoto Y, Ushikubi F, Ohuchida S, Kondo K, Nakamura T, Narumiya S 2002 Stimulation of bone formation and prevention of bone loss by prostaglandin EP4 receptor activation. Proc Natl Acad Sci USA 99:4580-4585.
29. Pullig O, Weseloh G, Gauer S, Swoboda B 2000 Osteopontin is expressed by adult human osteoarthritic chondrocytes: Protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol 19:245-255.
30. Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR 2001 Osteopontin: An intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 44:578-584.
31. Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M 2002 Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 99:4556-4561.
32. Beier F, Ali Z, Mok D, Taylor AC, Leask T, Albanese C, Pestell RG, Lu Valle P 2001 TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol Biol Cell 12:3852-3863.
33. Beier F, Lee RJ, Taylor AC, Pestell RG, Lu Valle P 1999 Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc Natl Acad Sci USA 96:1433-1438.
34. Davies SR, Sakano S, Zhu Y, Sandell LJ 2002 Distribution of the transcription factors Sox9, AP-2, and [delta]EF1 in adult murine articular and meniscal cartilage and growth plate. J Histochem Cytochem 50:1059-1065.
35. Pfisterer P, Ehlermann J, Hegen M, Schorle H 2002 A subtractive gene expression screen suggests a role of transcription factor AP-2 alpha in control of proliferation and differentiation. J Biol Chem 277:6637-6644.
36. Yasuda T, Poole AR 2002 A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum 46:138-148.
37. Homandberg GA, Wen C, Hui F 1998 Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage 6:231-244.
38. Homandberg GA 1999 Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci 4:D713-D730.
39. Homandberg GA, Costa V, Ummadi V, Pichika R 2002 Anti-sense oligonucleotides to the integrin receptor subunit alpha(5) decrease fibronectin fragment mediated cartilage chondrolysis. Osteoarthritis Cartilage 10:381-393.
40. Enomoto-Iwamoto M, Iwamoto M, Nakashima K, Mukudai Y, Boettiger D, Pacifici M, Kurisu K, Suzuki F 1997 Involvement of alpha5beta1 integrin in matrix interactions and proliferation of chondrocytes. J Bone Miner Res 12:1124-1132.
41. Forsyth CB, Pulai J, Loeser RF 2002 Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 46:2368-2376.
42. Pulai JI, Del Carlo M Jr, Loeser RF 2002 The alpha5beta1 integrin provides matrix survival signals for normal and osteo-arthritic human articular chondrocytes in vitro. Arthritis Rheum 46:1528-1535.
43. Masters SC, Yang H, Datta SR, Greenberg ME, Fu H 2001 14-3-3 inhibits Bad-induced cell death through interaction with serine-136. Mol Pharmacol 60:1325-1331.
44. Masters SC, Fu H 2001 14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem 276:45193-45200.
45. Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H 2002 Survival-promoting functions of 14-3-3 proteins. Biochem Soc Trans 30:360-365.
46. 2 in human colon cancer cells. Cancer Res 58:362-366.
47. Sanchez T, Moreno JJ 2002 Role of EP(1) and EP(4) PGE(2) subtype receptors in serum-induced 3T6 fibroblast cycle progression and proliferation. Am J Physiol Cell Physiol 282:C280-C288.
48. Kawamori T, Uchiya N, Sugimura T, Wakabayashi K 2003 Enhancement of colon carcinogenesis by prostaglandin E2 administration. Carcinogenesis 24:985-990.
49. Jabbour HN, Boddy SC 2003 Prostaglandin E2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway. J Clin Endocrinol Metab 88:4481-4487.
50. Yau L, Zahradka P PGE(2) stimulates vascular smooth muscle cell proliferation via the EP2 receptor. Mol Cell Endocrinol 203:77-90.